The total pharmaceutical sales in Türkiye (Turkey) stood at 92.4 billion TRY in 2023. Forecasted data indicates a steady upward trajectory from 2024 to 2028, with sales values rising from 104.91 billion TRY in 2024 to 157.16 billion TRY in 2028. The year-on-year growth rates observed over this period are as follows:
• 2024: +13.5%
• 2025: +12.6%
• 2026: +11.1%
• 2027: +9.9%
• 2028: +8.9%
The compound annual growth rate (CAGR) from 2023 to 2028 is approximately 11.1%, underscoring a consistent increase in the pharmaceutical market size over the forecast period.
Future trends to watch for:
• Increasing investment in healthcare infrastructure and pharmaceutical R&D.
• Growth in demand for innovative therapies and personalized medicine.
• Expansion of universal healthcare coverage driving market access and affordability.
• Continued currency fluctuations impacting pricing and expenditure levels.
These trends indicate a robust growth trajectory for the Turkish pharmaceutical sector, paving the path for significant advancements and market opportunities.
